In summary, our study demonstrates that dysregulation of the TNF-α signaling axis—including upregulation of TNF-α, IL-1β, and MAP3K8—is a hallmark of high-grade astrocytomas and correlates with worse patient outcomes. Here, IL1B is linked to astrocytoma (excluding glioblastoma).